# FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)

> **NCT01071122** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 365 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Nifedipine (Adalat, BAYA1040) and Valsartan
- **DRUG:** Nifedipine (Adalat, BAYA1040)
- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT01071122
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2014-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071122

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071122, "FOCUS (Nifedipine GITS's Effect on Central Pressure Assessed by Applanation Tonometry)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01071122. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*